Skip to main content

Advertisement

SpringerLink
Log in

Stem Cell Therapy: Current Applications and Potential for Urology

  • Pediatric Urology (M Castellan and R Gosalbez, Section Editors)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Stem cell therapy holds the potential to revolutionize the treatment of a number of chronic conditions. Stem cells ability to home in on injured sites of the body, stimulate angiogenesis, tissue regeneration, immunomodulation, anti-inflammatory, and anti-fibrotic factors have attracted their use in the treatment of many conditions. Urology has registered one of the highest experimental successes using stem cell therapy. However, the rate of clinical applications is comparatively lower. This review takes a look at our efforts so far and what needs to be done in order to maximize the clinical benefit we can derive from stem cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–7.

    Article  CAS  PubMed  Google Scholar 

  2. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76.

    Article  CAS  PubMed  Google Scholar 

  3. Elnakish MT, Hassan F, Dakhlallah D, Marsh CB, Alhaider IA, Khan M. Mesenchymal stem cells for cardiac regeneration: translation to bedside reality. Stem Cells Int. 2012;2012:646038.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Scadden DT. The stem-cell niche as an entity of action. Nature. 2006;441(7097):1075–9.

    Article  CAS  PubMed  Google Scholar 

  5. Rosemann A. Why regenerative stem cell medicine progresses slower than expected. J Cell Biochem. 2014;115(12):2073–6.

    Article  CAS  PubMed  Google Scholar 

  6. Zheng GP, Ge MH, Shu Q, Rojas M, Xu J. World J Pediatr. 2013;9(3):197–211.

    Article  CAS  PubMed  Google Scholar 

  7. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009;54(24):2277–86.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004;94(1):92–5.

    Article  PubMed  Google Scholar 

  9. Williams AR, Trachtenberg B, Velazquez DL, McNiece I, Altman P, Rouy D, et al. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res. 2011;108(7):792–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Murry CE, Field LJ, Menasché P. Cell-based cardiac repair: reflections at the 10-year point. Circulation. 2005;112(20):3174–83.

    Article  PubMed  Google Scholar 

  11. Katritsis DG, Sotiropoulou PA, Karvouni E, Karabinos I, Korovesis S, Perez SA, et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv. 2005;65(3):321–9.

    Article  PubMed  Google Scholar 

  12. Katritsis DG, Sotiropoulou P, Giazitzoglou E, Karvouni E, Papamichail M. Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. Europace. 2007;9(3):167–71.

    Article  PubMed  Google Scholar 

  13. Mohyeddin-Bonab M, Mohamad-Hassani MR, Alimoghaddam K, Sanatkar M, Gasemi M, Mirkhani H, et al. Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction. Arch Iran Med. 2007;10(4):467–73.

    PubMed  Google Scholar 

  14. Amin MA, Sabry D, Rashed LA, Aref WM, el-Ghobary MA, Farhan MS, et al. Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study. Clin Transplant. 2013;27(4):607–12.

    Article  PubMed  Google Scholar 

  15. Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol. 2012;27 Suppl 2:112–20.

    Article  CAS  PubMed  Google Scholar 

  16. Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med. 2012;1:725–31.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Kharaziha P, Hellström PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol. 2009;21(10):1199–205.

    Article  CAS  PubMed  Google Scholar 

  18. Wang L, Li J, Liu H, Li Y, Fu J, Sun Y, et al. Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. J Gastroenterol Hepatol. 2013;28 Suppl 1:85–92.

    Article  CAS  PubMed  Google Scholar 

  19. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med. 2007;10(4):459–66.

    CAS  PubMed  Google Scholar 

  20. Peng L, Xie DY, Lin BL, Liu J, Zhu HP, Xie C, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes. Hepatology. 2011;54(3):820–8.

    Article  PubMed  Google Scholar 

  21. El-Ansary M, Abdel-Aziz I, Mogawer S, Abdel-Hamid S, Hammam O, Teaema S, et al. Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev. 2012;8(3):972–81.

    Article  CAS  PubMed  Google Scholar 

  22. Jang YO, Kim YJ, Baik SK, Kim MY, Eom YW, Cho MY, et al. Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. Liver Int. 2014;34(1):33–41.

    Article  CAS  PubMed  Google Scholar 

  23. Chambers DC, Enever D, Ilic N, Sparks L, Whitelaw K, Ayres J, et al. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology. 2014;19(7):1013.

    Article  PubMed  Google Scholar 

  24. Tzouvelekis A, Paspaliaris V, Koliakos G, Ntolios P, Bouros E, Oikonomou A, et al. A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. J Transl Med. 2013;11:171.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Li L, Zhang Y, Li Y, Yu B, Xu Y, Zhao S, et al. Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Transpl Int. 2008;21(12):1181–9.

    Article  CAS  PubMed  Google Scholar 

  26. Mias C, Lairez O, Trouche E, Roncalli J, Calise D, Seguelas MH, et al. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells. 2009;27(11):2734–43.

    Article  CAS  PubMed  Google Scholar 

  27. Ishikane S, Hosoda H, Yamahara K, Akitake Y, Kyoungsook J, Mishima K, et al. Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats. Transplantation. 2013;96(8):697–706.

    Article  CAS  PubMed  Google Scholar 

  28. Nasir GA, Mohsin S, Khan M, Shams S, Ali G, Khan SN, et al. Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice. J Transl Med. 2013;11:78.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Rabani V, Shahsavani M, Gharavi M, Piryaei A, Azhdari Z, Baharvand H. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression. Cell Biol Int. 2010;34(6):601–5.

    Article  PubMed  Google Scholar 

  30. Fang B, Shi M, Liao L, Yang S, Liu Y, Zhao RC. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation. 2004;78(1):83–8.

    Article  CAS  PubMed  Google Scholar 

  31. Zhang D, Jiang M, Miao D. Transplanted human amniotic membrane-derived mesenchymal stem cells ameliorate carbon tetrachloride-induced liver cirrhosis in mouse. PLoS One. 2011;6(2), e16789.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Wang Y, Lian F, Li J, Fan W, Xu H, Yang X, et al. Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats. J Transl Med. 2012;10:133.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, et al. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol. 2009;175(1):303–13.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol. 2007;213(2):341–7.

    Article  CAS  PubMed  Google Scholar 

  35. Semedo P, Correa-Costa M, Antonio Cenedeze M, Maria Avancini Costa Malheiros D, Antonia dos Reis M, Shimizu MH, et al. Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model. Stem Cells. 2009;27(12):3063–73.

    CAS  PubMed  Google Scholar 

  36. Bornes TD, Jomha NM, Mulet-Sierra A, Adesida AB. Hypoxic culture of bone marrow-derived mesenchymal stromal stem cells differentially enhances in vitro chondrogenesis within cell-seeded collagen and hyaluronic acid porous scaffolds. Stem Cell Res Ther. 2015;6(1):84.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Matthies NF, Mulet-Sierra A, Jomha NM, Adesida AB. Matrix formation is enhanced in co-cultures of human meniscus cells with bone marrow stromal cells. J Tissue Eng Regen Med. 2013;7(12):965–73.

    Article  CAS  PubMed  Google Scholar 

  38. Adesida AB, Mulet-Sierra A, Jomha NM. Hypoxia mediated isolation and expansion enhances the chondrogenic capacity of bone marrow mesenchymal stromal cells. Stem Cell Res Ther. 2012;3(2):9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Acharya C, Adesida A, Zajac P, Mumme M, Riesle J, Martin I, et al. Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. J Cell Physiol. 2012;227(1):88–97.

    Article  CAS  PubMed  Google Scholar 

  40. Saliken DJ, Mulet-Sierra A, Jomha NM, Adesida AB. Decreased hypertrophic differentiation accompanies enhanced matrix formation in co-cultures of outer meniscus cells with bone marrow mesenchymal stromal cells. Arthritis Res Ther. 2012. 14(3).

  41. Yamada Y, Nakamura S, Ito K, Umemura E, Hara K, Nagasaka T, et al. Injectable bone tissue engineering using expanded mesenchymal stem cells. Stem Cells. 2013;31(3):572–80.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Lee J, Sung HM, Jang JD, Park YW, Min SK, Kim EC. Successful reconstruction of 15-cm segmental defects by bone marrow stem cells and resected autogenous bone graft in central hemangioma. J Oral Maxillofac Surg. 2010;68(1):188–94.

    Article  PubMed  Google Scholar 

  43. Hibi H, Yamada Y, Ueda M, Endo Y. Alveolar cleft osteoplasty using tissue-engineered osteogenic material. Int J Oral Maxillofac Surg. 2006;35(6):551–5.

    Article  CAS  PubMed  Google Scholar 

  44. Mesimäki K, Lindroos B, Törnwall J, Mauno J, Lindqvist C, Kontio R, et al. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int J Oral Maxillofac Surg. 2009;38(3):201–9.

    Article  PubMed  Google Scholar 

  45. Shayesteh YS, Khojasteh A, Soleimani M, Alikhasi M, Khoshzaban A, Ahmadbeigi N. Sinus augmentation using human mesenchymal stem cells loaded into a beta-tricalcium phosphate/hydroxyapatite scaffold. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106(2):203–9.

    Article  PubMed  Google Scholar 

  46. Potter SJ, Thierstein ST. Glomerular development in the kidney as an index of fetal maturity. J Pediatr. 1943;22:695–706.

    Article  Google Scholar 

  47. Abdel Aziz MT, Abdel Aziz MT, Atta HM, Atta HM, Mahfouz S, Mahfouz S, et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem. 2007;40(12):893–9.

    Article  CAS  PubMed  Google Scholar 

  48. Zhao D-C, Zhao D-C, Lei J-X, Lei J-X, Chen R, Chen R, et al. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol. 2005;11(22):3431–40.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Duffield JS, Park KM, Hsiao LL, Kelley VR, Scadden DT, Ichimura T, et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest. 2005;115(7):1743–55.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. Caldas HC, de Paula Couto TA, Fernandes IM, Baptista MA, Kawasaki-Oyama RS, Goloni-Bertollo EM, Braile DM, Abbud-Filho M. Comparative effects of mesenchymal stem cell therapy in distinct stages of chronic renal failure. Clin Exp Nephrol. 2015. PMID: 25630669.

  51. Wu HJ, Yiu WH, Li RX, Wong DW, Leung JC, Chan LY, et al. Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis. PLoS One. 2014;9(3), e90883.

    Article  PubMed Central  PubMed  Google Scholar 

  52. Oliveira-Sales EB, Maquigussa E, Semedo P, Pereira LG, Ferreira VM, Câmara NO, et al. Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture. PLoS One. 2013;8(11), e78464.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Alfarano C, Roubeix C, Chaaya R, Ceccaldi C, Calise D, Mias C, et al. Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats. Cell Transplant. 2012;21(9):2009–19.

    Article  CAS  PubMed  Google Scholar 

  54. Donizetti-Oliveira C, Semedo P, Burgos-Silva M, Cenedeze MA, Malheiros DM, Reis MA, et al. Adipose tissue-derived stem cell treatment prevents renal disease progression. Cell Transplant. 2012;21(8):1727–41.

    Article  PubMed  Google Scholar 

  55. Asanuma H, Vanderbrink BA, Campbell MT, Hile KL, Zhang H, Meldrum DR, et al. Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J Surg Res. 2011;168(1):e51–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  56. Papazova DA, Oosterhuis NR, Gremmels H, van Koppen A, Joles JA, Verhaar MC. Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis. Dis Model Mech. 2015;8(3):281–93. This is article reports a carefully planned, well-executed systematic review with a meta-analysis that gives us a clear picture of the preclinical work done so far in chronic renal disease models. Thus, the reported efficacy of MSCs in chronic kidney disease models is one that is statistically validated.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  57. Tan J, Wu W, Xu X, Liao L, Zheng F, Messinger S, et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial. JAMA. 2012;307(11):1169–77. This manuscript elaborately describes a randomized control trial of 159 patients with terminal renal disease undergoing kidney transplant. The ability of injected autologous MSCs to suppress immunity and prevent acute tissue rejection was compared with the traditional use of antibody-based induction therapy with calcineurin inhibitors. This study reports better improvement in kidney function and a lower incidence of acute rejection and opportunistic infections.

    Article  CAS  PubMed  Google Scholar 

  58. Reinders ME, de Fijter JW, Roelofs H, Bajema IM, de Vries DK, Schaapherder AF, et al. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med. 2013;2(2):107–11.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  59. Tögel FE, Westenfelder C. Kidney protection and regeneration following acute injury: progress through stem cell therapy. Am J Kidney Dis. 2012;60(6):1012–22.

    Article  PubMed  Google Scholar 

  60. Metcalfe PD, Wang J, Jiao H, Huang Y, Hori K, Moore RB, et al. Bladder outlet obstruction: progression from inflammation to fibrosis. BJU Int. 2010;106(11):1686–94.

    Article  PubMed  Google Scholar 

  61. Woo LL, Tanaka ST, Anumanthan G, Pope 4th JC, Thomas JC, Adams MC, et al. Mesenchymal stem cell recruitment and improved bladder function after bladder outlet obstruction: preliminary data. J Urol. 2011;185(3):1132–8.

    Article  PubMed  Google Scholar 

  62. Lee HJ, Won JH, Doo SH, Kim JH, Song KY, Lee SJ, et al. Inhibition of collagen deposit in obstructed rat bladder outlet by transplantation of superparamagnetic iron oxide-labeled human mesenchymal stem cells as monitored by molecular magnetic resonance imaging (MRI). Cell Transplant. 2012;21(5):959–70.

    Article  PubMed  Google Scholar 

  63. Lin G, Wang G, Banie L, Ning H, Shindel AW, Fandel TM, et al. Treatment of stress urinary incontinence with adipose tissue-derived stem cells. Cytotherapy. 2010;12(1):88–95.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  64. Fu Q, Song XF, Liao GL, Deng CL, Cui L. Myoblasts differentiated from adipose-derived stem cells to treat stress urinary incontinence. Urology. 2010;75(3):718–23.

    Article  PubMed  Google Scholar 

  65. Kim SO, Na HS, Kwon D, Joo SY, Kim HS, Ahn Y. Bone-marrow-derived mesenchymal stem cell transplantation enhances closing pressure and leak point pressure in a female urinary incontinence rat model. Urol Int. 2011;86(1):110–6.

    Article  PubMed  Google Scholar 

  66. Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R, et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(6):881–3.

    Article  CAS  PubMed  Google Scholar 

  67. Carr LK, Robert M, Kultgen PL, Herschorn S, Birch C, Murphy M, et al. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. J Urol. 2013;189(2):595–601.

    Article  PubMed  Google Scholar 

  68. Gotoh M, Yamamoto T, Kato M, Majima T, Toriyama K, Kamei Y, et al. Regenerative treatment of male stress urinary incontinence by periurethral injection of autologous adipose-derived regenerative cells: 1-year outcomes in 11 patients. Int J Urol. 2014;21(3):294–300.

    Article  PubMed  Google Scholar 

  69. Mitterberger M, Pinggera GM, Marksteiner R, Margreiter E, Fussenegger M, Frauscher F, et al. Adult stem cell therapy of female stress urinary incontinence. Eur Urol. 2008;53(1):169–75.

    Article  PubMed  Google Scholar 

  70. Gerullis H, Eimer C, Georgas E, Homburger M, El-Baz AG, Wishahi M, et al. Muscle-derived cells for treatment of iatrogenic sphincter damage and urinary incontinence in men. ScientificWorldJournal. 2012;2012:898535.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  71. Kuismanen K, Sartoneva R, Haimi S, Mannerström B, Tomás E, Miettinen S, et al. Autologous adipose stem cells in treatment of female stress urinary incontinence: results of a pilot study. Stem Cells Transl Med. 2014;3(8):936–41.

    Article  PubMed Central  PubMed  Google Scholar 

  72. Stangel-Wojcikiewicz K, Jarocha D, Piwowar M, Jach R, Uhl T, Basta A, et al. Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2-year follow-up of a Polish investigation. Neurourol Urodyn. 2014;33(3):324–30.

    Article  PubMed  Google Scholar 

  73. Pariente JL, Kim BS, Atala A. In vitro biocompatibility assessment of naturally derived and synthetic biomaterials using normal human urothelial cells. J Biomed Mater Res. 2001;55(1):33–9.

    Article  CAS  PubMed  Google Scholar 

  74. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006;367(9518):1241–6.

    Article  PubMed  Google Scholar 

  75. Humes HD, Weitzel WF, Bartlett RH, Swaniker FC, Paganini EP, Luderer JR, et al. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int. 2004;66(4):1578–88.

    Article  CAS  PubMed  Google Scholar 

  76. Dublin N, Stewart LH. Oral complications after buccal mucosal graft harvest for urethroplasty. BJU Int. 2004;94(6):867–9.

    Article  PubMed  Google Scholar 

  77. Mundy AR. The long-term results of skin inlay urethroplasty. Br J Urol. 1995;75(1):59–61.

    Article  CAS  PubMed  Google Scholar 

  78. el-Kassaby A, AbouShwareb T, Atala A. Randomized comparative study between buccal mucosal and acellular bladder matrix grafts in complex anterior urethral strictures. J Urol. 2008;179(4):1432–6.

    Article  PubMed  Google Scholar 

  79. El-Kassaby AW, Retik AB, Yoo JJ, Atala A. Urethral stricture repair with an off-the-shelf collagen matrix. J Urol. 2003;169(1):170–3.

    Article  CAS  PubMed  Google Scholar 

  80. Atala A, Guzman L, Retik AB. A novel inert collagen matrix for hypospadias repair. J Urol. 1999;162(3 Pt 2):1148–51.

    Article  CAS  PubMed  Google Scholar 

  81. Li CL, Liao WB, Yang SX, Song C, Li YW, Xiong YH, et al. Urethral reconstruction using bone marrow mesenchymal stem cell- and smooth muscle cell-seeded bladder acellular matrix. Transplant Proc. 2013;45(9):3402–7.

    Article  CAS  PubMed  Google Scholar 

  82. Mahfouza W, Elsalmya S, Corcos J, Fayeda AS. Fundamentals of bladder tissue engineering. Afr J Urol. 2013;19(3):51–7.

    Article  Google Scholar 

  83. Bharadwaj S, Liu G, Shi Y, Wu R, Yang B, He T, et al. Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology. Stem Cells. 2013;31(9):1840–56. This study takes a step further to uniquely demonstrate the multipotency of urine-derived stem cells. A report of their high telomerase activity and in vivo differentiation without teratoma formation makes them potentially an attractive source of stem cells for clinical applications.

    Article  CAS  PubMed  Google Scholar 

  84. Lonnemann G, Engler-Blum G, Müller GA, Koch KM, Dinarello CA. Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts. Kidney Int. 1995;47(3):845–54.

    Article  CAS  PubMed  Google Scholar 

  85. El Awad B, Kreft B, Wolber EM, Hellwig-Bürgel T, Metzen E, Fandrey J, et al. Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in human proximal tubular cells. Kidney Int. 2000;58(1):43–50.

    Article  PubMed  Google Scholar 

  86. Yildirim A, Başeskioğlu B, Temel HE, Erkasap N, Yenilmez A, Uslu S, et al. Effect of αlipoic acid and silymarin on bladder outlet obstruction. Exp Ther Med. 2013;5(2):596–602.

    PubMed Central  CAS  PubMed  Google Scholar 

  87. Wang Z, Cheng Z, Cristofaro V, Li J, Xiao X, Gomez P, et al. Inhibition of TNF-α improves the bladder dysfunction that is associated with type 2 diabetes. Diabetes. 2012;61(8):2134–45.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  88. Ren G, Zhang L, Zhao X, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2(2):141–50.

    Article  CAS  PubMed  Google Scholar 

  89. English K, Barry FP, Field-Corbett CP, Mahon BP. IFN-γ and TNF-α differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol Lett. 2007;110(2):91–100.

    Article  CAS  PubMed  Google Scholar 

  90. Ortiz LA, Dutreil M, Fattman C, et al. Interleukin 1 receptor antagonist mediates the anti-inflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A. 2007;104(26):11002–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  91. Raffaghello L, Bianchi G, Bertolotto M, et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells. 2008;26(1):151–62.

    Article  CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Bridget Wiafe, Peter Metcalfe, and Adetola Adesida each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. 3-007 Li Ka Shing Centre for Health Research Innovation, University of Alberta, Edmonton, AB, Canada, T6G 2E1

    Bridget Wiafe

  2. 2C3.79 WMC, 8440-112 Street, Edmonton, AB, T6G 2B7, Canada

    Peter D. Metcalfe

  3. 3-002E Li Ka Shing Centre for Health Research Innovation, University of Alberta, Edmonton, AB, Canada, T6G 2E1

    Adetola B. Adesida

Authors
  1. Bridget Wiafe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter D. Metcalfe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adetola B. Adesida
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter D. Metcalfe.

Additional information

This article is part of the Topical Collection on Pediatric Urology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wiafe, B., Metcalfe, P.D. & Adesida, A.B. Stem Cell Therapy: Current Applications and Potential for Urology. Curr Urol Rep 16, 77 (2015). https://doi.org/10.1007/s11934-015-0551-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11934-015-0551-5

Keywords

Search

Navigation